Diabetic Siltussin DAS-Na description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Diabetic Siltussin DAS-Na

Silarx Pharmaceuticals, Inc

Diabetic Siltussin DAS-Na


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Active ingredient

Active Ingredient: Guaifenesin 100 mg (in each 5 mL)

Purpose

Purpose: Expectorant

Uses

Uses

Helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive.

Warnings


Ask a doctor before use if you have

  • cough that occurs with too much phlegm (mucus)
  • cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema

Stop use and ask a doctor if cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • do not take more than 6 doses in any 24-hour period repeat dose every 4 hours

Adult and children 12 years and over
2 teaspoonfuls
Children under 12 years
DO NOT USE

Other information
store at room temperature 20°-25°C (68°-77°F)

Phenylketonurics: contains phenylalanine 3 mg per teaspoonful (5 mL)

Inactive Ingredients

Acesulfame-K, aspartame, benzoic acid, citric acid, hydroxypropyl methyl cellulose, methylparaben, propylene glycol, strawberry flavor, and water.

Questions

888-974-5279

* This product is not manufactured or distributed by Wyeth Consumer Healthcare, distributor of Robitussin®

Manufactured by:

Silarx Pharmaceuticals, Inc.
1033 Stoneleigh Ave,
Carmel, NY 10512
USA


Diabetic Siltussin DAS-Na

Diabetic Siltussin DAS-Na

Guaifenesin LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:54838-138
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Guaifenesin GUAIFENESIN 100 mg

Inactive Ingredients

Ingredient Name Strength
ACESULFAME POTASSIUM
ASPARTAME
BENZOIC ACID
ANHYDROUS CITRIC ACID
HYPROMELLOSE 2910 (4000 MPA.S)
METHYLPARABEN
propylene glycol
water

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:54838-138-40 118 in 1 BOTTLE, PLASTIC

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part341 2005-12-05


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.